staceywhite, Author at European Medical Journal - Page 24 of 195

Neurocritical Care Innovations: Interview with Ryan Hakimi

Ryan Hakimi – President American Society of Neuroimaging (ASN); Executive Committee Member, Neurocritical Care Society Board of Directors…

Treatment of Urolithiasis: A Comprehensive Review

Urolithiasis is a highly prevalent and multifactorial disease, representing the most common urological condition globally. Its incidence…

Dermatology Beneath the Surface: An Interview with Jason Hawkes

EMJ spoke to Dr Jason Hawkes, Dermatologist, Co-owner, Chief Scientific Officer, and Investigator at the Oregon Medical Research Center…

Meet the Experts: What to do with a positive urine marker test?

Join Fred Witjes and Param Mariappan as they present new scientific evidence on urine bladder cancer biomarkers that delves into the…

Efficacy of Intralesional Vitamin D3 for Verruca Vulgaris Treatment

Cutaneous warts are benign epithelial lesions caused by human papillomavirus (HPV) and are common entities, affecting nearly 10% of the…

Determinants of Therapeutic Resistance in Pediatric Atopic Dermatitis

Atopic dermatitis (AD) is a chronic skin condition affecting children, often influenced by various environmental and behavioral factors…

Scarring Alopecias in a Pediatric Trichology Clinic

Scarring alopecias (SA) are uncommon, and despite their morbidity, research on pediatric patients remains limited. Data on the most…

Concerns with Cosmetic Procedures in Skin of Color

In the United States, patients with skin of color (SOC) face significant healthcare disparities. Recognizing and addressing the…

Ethics of Treating Actinic Keratosis in Patients of Advanced Age

This ethics discussion highlights the complexities of treating actinic keratoses (AK) in elderly patients, particularly those in their…

Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy?

Acral digital ischemia associated with immune checkpoint inhibitor (ICI) use is a rare and poorly understood toxicity. The authors report…